We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGL icon
4251
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
$13K ﹤0.01%
491
+391
+391% +$10.8K
AOMR
4252
Angel Oak Mortgage REIT
AOMR
$208M
$13K ﹤0.01%
1,119
-360
-24% -$5.08K
ASTC icon
4253
Astrotech Corp
ASTC
$16.9M
$13K ﹤0.01%
995
+413
+71% +$5.7K
BCTX
4254
Briacell Therapeutics
BCTX
$29.5M
$13K ﹤0.01%
15
-7
-32% -$7.02K
BEAT icon
4255
Heartbeam
BEAT
$27.8M
$13K ﹤0.01%
3,389
-1,938
-36% -$3.09K
BIB icon
4256
ProShares Ultra NASDAQ Biotechnology
BIB
$85.7M
$13K ﹤0.01%
278
-13,799
-98% -$735K
BNR
4257
Burning Rock Biotech
BNR
$96.7M
$13K ﹤0.01%
539
-34
-6% -$1.1K
BRBS icon
4258
Blue Ridge Bankshares
BRBS
$333M
$13K ﹤0.01%
1,028
-286
-22% -$4.14K
CADL icon
4259
Candel Therapeutics
CADL
$857M
$13K ﹤0.01%
4,137
+2,918
+239% +$9.89K
CSTE icon
4260
Caesarstone
CSTE
$116M
$13K ﹤0.01%
1,444
+259
+22% +$2.49K
CVAC
4261
DELISTED
CureVac
CVAC
$13K ﹤0.01%
1,619
-2,211
-58% -$25.8K
CYH icon
4262
Community Health Systems
CYH
$426M
$13K ﹤0.01%
5,937
-15,898
-73% -$52.7K
DIBS icon
4263
1stdibs.com
DIBS
$162M
$13K ﹤0.01%
2,104
+697
+50% +$4.51K
DVOL icon
4264
First Trust Dorsey Wright Momentum & Low Volatility ETF
DVOL
$74.3M
$13K ﹤0.01%
552
+67
+14% +$1.74K
FOR icon
4265
Forestar Group
FOR
$1.49B
$13K ﹤0.01%
1,163
-3,485
-75% -$46.1K
GCT icon
4266
GigaCloud Technology
GCT
$1.88B
$13K ﹤0.01%
+1,251
New +$23.7K
GORO icon
4267
Goldgroup Mining Inc.
GORO
$212M
$13K ﹤0.01%
7,931
-7,886
-50% -$13.4K
GTX icon
4268
Garrett Motion
GTX
$5.42B
$13K ﹤0.01%
2,228
HUMA icon
4269
Humacyte
HUMA
$164M
$13K ﹤0.01%
3,988
-2,707
-40% -$10.4K
IDAI icon
4270
T Stamp
IDAI
$14.3M
$13K ﹤0.01%
171
+83
+94% +$8.7K
IMA
4271
ImageneBio Inc
IMA
$66.4M
$13K ﹤0.01%
320
+56
+21% +$3.24K
IMNN icon
4272
Imunon
IMNN
$6.93M
$13K ﹤0.01%
614
-405
-40% -$11.4K
ITOT icon
4273
iShares Core S&P Total US Stock Market ETF
ITOT
$98.3B
$13K ﹤0.01%
164
+121
+281% +$10.7K
KTCC icon
4274
Key Tronic
KTCC
$42M
$13K ﹤0.01%
3,100
+1,954
+171% +$9.12K
NAUT icon
4275
Nautilus Biotechnolgy
NAUT
$114M
$13K ﹤0.01%
6,235
-13,251
-68% -$33.3K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.